Skip to main content

Table 1 Baseline characteristics and pregnancy outcomes of women with imminent preterm birth at participating Canadian Perinatal Network sites (2005–15) (N (%) women or median [IQR], unless otherwise stated)

From: MAGnesium sulphate for fetal neuroprotection to prevent Cerebral Palsy (MAG-CP)—implementation of a national guideline in Canada

 

Total

N = 7888

Pre-MAG-CP (2005–2011)

N = 4745

MAG-CP (2011–2015)

N = 3143

p values

Maternal demographics and past history

Maternal age at EDD (year)

31 [27, 35]

31 [27,35]

31 [27,35]

0.034

Pre-existing medical conditions

 Pre-existing hypertension

305 (3.9%)

178 (3.8%)

127 (4.0%)

0.600

 Diabetes mellitus

149 (1.9%)

79 (1.7%)

70 (2.2%)

0.090

 Venous thromboembolism

28 (0.4%)

25 (0.5%)

3 (0.1%)

0.001

Prior obstetric history

 Previous preterm birth

1383 (17.5%)

845 (17.8%)

538 (17.1%)

0.400

 Previous caesarean

930 (11.8%)

666 (14.0%)

264 (8.4%)

< 0.001

Current pregnancy

Nulliparity

3909 (49.6%)

2303 (48.5%)

1606 (51.1%)

0.030

Multiple gestation

1507 (19.1%)

911 (19.2%)

596 (19.0%)

0.800

Smoking during pregnancy

1260 (16.0%)

833 (17.6%)

427 (13.6%)

< 0.001

 Missing

52

33

19

 

Gestational age at enrollment (week)

26.0 [24.4, 27.4]

26.1 [24.6, 27.6]

25.9 [24.4, 27.4]

< 0.001

Indication for threatened preterm birth

 Preterm labour only

2324 (29.5%)

1375 (29.0%)

949 (30.2%)

< 0.001

 PPROM only

1567 (19.9%)

960 (20.2%)

607 (19.9%)

 PTL and PPROM

1106 (14.0%)

591 (12.5%)

515 (16.4%)

 Antepartum haemorrhage only

1195 (15.1%)

764 (16.1%)

431 (13.7%)

 Other†

1696 (21.5%)

1055 (22.2%)

641 (20.4%)

Gestational age at delivery (week)

28.0 [26.0, 35.0]

28.0 [26.0, 35.0]

28.0 [26.0, 34.0]

0.036

 ≥ 37 weeks (and 0 days)

1404 (17.8%)

889 (18.7%)

515 (16.4%)

0.008

 34 weeks (and 0 days)–36 weeks (and 6 days)

821 (10.4%)

507 (10.7%)

314 (10.0%)

 29 weeks (and 0 days)–33 weeks (and 6 days)

1522 (19.3%)

926 (19.5%)

596 (19.0%)

 < 29 weeks (and 0 days)

4141 (52.5%)

2423 (51.1%)

1718 (54.7%)

Maternal outcomes

 Placental abruption after enrollment

635 (8.1%)

251 (5.3%)

384 (12.2%)

< 0.001

 One/more serious maternal complications

2479 (31.4%)

1304 (27.5%)

1175 (37.4%)

< 0.001

  Death

2 (0.03%)

2 (0.04%)

0

0.500

  Admission to ICU or HDU

98 (1.2%)

19 (0.4%)

79 (2.5%)

< 0.001

  Chorioamnionitis

1789 (22.7%)

999 (21.1%)

790 (25.1%)

< 0.001

  Cardiovascular

2 (0.03%)

1 (0.02%)

1 (0.03%)

0.999

  Respiratory

64 (0.8%)

38 (0.8%)

26 (0.8%)

0.999

  CNS

7 (0.09%)

5 (0.1%)

2 (0.06%)

0.700

  Renal

6 (0.08%)

4 (0.08%)

2 (0.06%)

0.999

  Hematological

72 (0.9%)

37 (0.8%)

17 (0.5%)

0.300

  Hepatic

11 (0.1%)

11 (0.2%)

0

0.004

  Infection

74 (0.9%)

50 (1.1%)

24 (0.8%)

0.200

Perinatal outcomes

N = 9541

N = 5751

N = 3790

 

 Stillbirth

291 (3.0%)

211 (3.7%)

80 (2.1%)

< 0.001

 Neonatal death in the delivery room

164 (1.7%)

119 (2.1%)

45 (1.2%)

0.002

 Liveborn and admitted to NICU

7638 (80.1%)

4714 (82.0%)

2924 (77.2%)

<0.001

  1. PPROM preterm premature rupture of membranes, CNS central nervous system, HDU high-dependency unit, ICU intensive care unit, IQR interquartile range, NICU neonatal intensive care unit
  2. †Other indications for threatened preterm birth in the absence of preterm labour, PPROM or antepartum haemorrhage included (not mutually exclusive) gestational hypertension (N = 227), intrauterine growth restriction (N = 238), short cervix (N = 476), prolapsed membranes (N = 249) or other non-CPN condition within the Maternal-Infant Care Network (N = 48) in the pre-MAG-CP era and gestational hypertension (N = 137), intrauterine growth restriction (N = 151), short cervix (N = 325) or prolapsed membranes (N = 157) in the MAG-CP era